Stock Price Forecast

April 17, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Progyny, Inc. chart...

About the Company

We do not have any company description for Progyny, Inc. at the moment.

Exchange

Nasdaq

$1B

Total Revenue

441

Employees

$3B

Market Capitalization

0.41

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PGNY News

Insider Sell: President Michael Sturmer Sells Shares of Progyny Inc (PGNY)

14d ago, source: Yahoo Finance

Michael Sturmer, President at Progyny Inc (NASDAQ:PGNY), sold 6,395 shares of the company on April 1, 2024, according to a ...

Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care

1d ago, source:

In 2007, FMC launched Canadian Infertility Awareness Week (CIAW) to raise awareness and hope in the fertility community. In 2023, CIAW became Canadian Fertility Awareness Week (CFAW), a more inclusive ...

Progyny (NASDAQ: PGNY)

2d ago, source: The Motley Fool

Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments.

Progyny, Inc. Announces Fourth Quarter 2023 Results

1mon ago, source: Nasdaq

Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a transformative fertility, family building and women's health benefits solution, today announced its financial results for the ...

Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum

1mon ago, source: Stockhouse

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete ...

Progyny Inc.

6d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Progyny executive chairman sells $37,522 in stock

14d ago, source: Investing

In a recent transaction, David J. Schlanger, the Executive Chairman of Progyny, Inc. (NASDAQ:PGNY), sold shares of the company's common stock, according to the latest SEC filings. Schlanger sold ...

Progyny CFO sells over $419k in company stock

14d ago, source: Investing

Mark S. Livingston, the Chief Financial Officer of Progyny, Inc. (NASDAQ:PGNY), has recently engaged in significant trading activity involving the company's stock, according to the latest filings.

Executive Chairman David Schlanger Sells 71,272 Shares of Progyny Inc (PGNY)

19d ago, source: Yahoo Finance

Executive Chairman David Schlanger of Progyny Inc (NASDAQ:PGNY) has sold 71,272 shares of the company on March 27, 2024, ...

Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum

1mon ago, source: Morningstar

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski ...

Progyny executive chairman sells $37,522 in stock

14d ago, source: Investing

In a recent transaction, David J. Schlanger, the Executive Chairman of Progyny, Inc. (NASDAQ:PGNY), sold shares of the company's common stock, according to the latest SEC filings. Schlanger sold 1,000 ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...